Lava Therapeutics N.V. (LVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35,015 | 44,231 | 100,333 | 90,869 | 15,818 |
| Marketable Securities | 41,561 | 51,340 | 32,535 | 42,334 | N/A |
| Receivables | N/A | N/A | 3,254 | 734 | 1,476 |
| Other current assets | 1,649 | 1,699 | 0 | 0 | 811 |
| TOTAL | $79,297 | $98,897 | $140,533 | $136,505 | $18,222 |
| Non-Current Assets | |||||
| PPE Net | 1,002 | 1,602 | 1,432 | 1,445 | 1,113 |
| Other Non-Current Assets | 532 | 1,174 | 1,460 | 1,297 | 1,151 |
| TOTAL | $1,534 | $2,776 | $2,892 | $2,742 | $2,264 |
| Total Assets | $80,831 | $101,673 | $143,425 | $139,247 | $20,486 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,886 | 5,282 | 4,640 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,722 | 4,446 | 4,010 | 2,553 | 934 |
| Accrued Expenses | 10,083 | 4,751 | 8,193 | 1,879 | 1,673 |
| Other current liabilities | N/A | N/A | 4,732 | 5,028 | N/A |
| TOTAL | $18,006 | $14,894 | $21,954 | $11,248 | $7,335 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 4,284 | 3,604 |
| Deferred Revenues | N/A | N/A | N/A | 1,527 | 4,521 |
| Other Non-Current Liabilities | 80 | 415 | 0 | 5,028 | 0 |
| TOTAL | $35,080 | $35,415 | $35,431 | $9,632 | $5,530 |
| Total Liabilities | $53,086 | $50,309 | $57,385 | $20,880 | $12,865 |
| Shareholders' Equity | |||||
| Common Shares | 3,717 | 3,715 | 3,715 | 3,653 | N/A |
| Retained earnings | -174,973 | -149,859 | N/A | -76,162 | -33,386 |
| Other shareholders' equity | -12,655 | -10,897 | -4,030 | -1,394 | -81 |
| TOTAL | $27,745 | $51,364 | $86,040 | $118,367 | $7,621 |
| Total Liabilities And Equity | $80,831 | $101,673 | $143,425 | $139,247 | $20,486 |